These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21572523)

  • 21. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
    Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M
    Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic and socioeconomic factors associated with leprosy treatment default: An analysis from the 100 Million Brazilian Cohort.
    de Andrade KVF; Silva Nery J; Moreira Pescarini J; Ramond A; de Souza Teles Santos CA; Ichihara MY; Fernandes Penna ML; B Brickley E; C Rodrigues L; Smeeth L; L Barreto M; Martins Pereira S; Oliveira Penna G
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007714. PubMed ID: 31490925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary diversity and poverty as risk factors for leprosy in Indonesia: A case-control study.
    Oktaria S; Hurif NS; Naim W; Thio HB; Nijsten TEC; Richardus JH
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006317. PubMed ID: 29534113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
    Lim JT; Tan T
    Lepr Rev; 1993 Jun; 64(2):136-42. PubMed ID: 8341116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on non-adherence to MDT among leprosy patients.
    Rao PS
    Indian J Lepr; 2008; 80(2):149-54. PubMed ID: 19425509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migration among individuals with leprosy: a population-based study in central Brazil.
    Murto C; Ariza L; Alencar CH; Chichava OA; Oliveira AR; Kaplan C; Silva LF; Heukelbach J
    Cad Saude Publica; 2014 Mar; 30(3):487-501. PubMed ID: 24714939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motives and determinants for residence change after leprosy diagnosis, central Brazil.
    Murto C; Ariza L; Oliveira AR; Chichava OA; Alencar CH; Da Silva LF; Tanner M; Heukelbach J
    Lepr Rev; 2012 Mar; 83(1):16-23. PubMed ID: 22655466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.
    Richardus JH; Finlay KM; Croft RP; Smith WC
    Lepr Rev; 1996 Dec; 67(4):297-305. PubMed ID: 9033200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary assessment of multidrug therapy in leprosy patients in Western Samoa.
    Paksoy N; Levi V
    N Z Med J; 1989 Nov; 102(879):589-91. PubMed ID: 2812597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defaulting patterns in a provincial leprosy control programme in Northern Mozambique.
    Griffiths S; Ready N
    Lepr Rev; 2001 Jun; 72(2):199-205. PubMed ID: 11495451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People's Republic of China.
    Courtright P; Hu LF; Li HY; Lewallen S
    Int J Epidemiol; 1994 Aug; 23(4):835-42. PubMed ID: 8002199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress and impact of multidrug therapy (MDT) implementation to leprosy control in Thailand.
    Ramasoota P; Intaratitaya T
    Nihon Rai Gakkai Zasshi; 1995 Nov; 64(3):214-9. PubMed ID: 8582880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprophylaxis against leprosy: expectations and methodology of a trial.
    Vijayakumaran P; Krishnamurthy P; Rao P; Declerq E
    Lepr Rev; 2000 Dec; 71 Suppl():S37-40; discussion S40-1. PubMed ID: 11201885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding non-compliance with WHO-multidrug therapy among leprosy patients in Assam, India.
    Kar S; Pal R; Bharati DR
    J Neurosci Rural Pract; 2010 Jan; 1(1):9-13. PubMed ID: 21799610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does MDT arrest transmission of leprosy to household contacts?
    Vijayakumaran P; Jesudasan K; Mozhi NM; Samuel JD
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):125-30. PubMed ID: 9728444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iris atrophy in patients with newly diagnosed multibacillary leprosy: at diagnosis, during and after completion of multidrug treatment.
    Daniel E; Sundar Rao PS; Ffytche TJ; Chacko S; Prasanth HR; Courtright P
    Br J Ophthalmol; 2007 Aug; 91(8):1019-22. PubMed ID: 17108015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intolerance to leprosy multi-drug therapy: more common in women?
    Dupnik KM; Cardoso FJ; De Macêdo AL; De Sousa IL; Leite RC; Jerônimo SM; Nobre ML
    Lepr Rev; 2013 Sep; 84(3):209-18. PubMed ID: 24428115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paucibacillary leprosy patients treated with multidrug therapy four years experience (1988 to 1991) in Bangladesh.
    Faruque E; Hoque AK; Ahmed J; Ahmed R; Ali A
    Nihon Rai Gakkai Zasshi; 1994 Nov; 63(3):95-8. PubMed ID: 7730212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.